Post-approval studies (Phase 4)Study completedNCT00855738
What this trial is testing
A Prospective, Observational Study On The Effectiveness Of New Antiepileptic Drugs As First Bitherapy In The Daily Clinical Practice
Who this might be right for
Focal Epilepsy
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 111